Mazdutide

Research Guide · Laboratory Use Only

GLP-1 / glucagon dual agonist

Mazdutide is a dual agonist targeting both the GLP-1 and glucagon receptors, part of the newer generation of multi-receptor metabolic peptides.

What it is

By engaging GLP-1 receptors (incretin, satiety) and glucagon receptors (energy expenditure), mazdutide is studied as a model of how dual-pathway activation shapes metabolic outcomes differently from single-target GLP-1 agonists.

How it’s studied

Research focuses on the combined incretin-plus-glucagon mechanism and comparisons across the dual- and triple-agonist class.

Research focus areas

  • Combined GLP-1 and glucagon-receptor signaling
  • Energy-expenditure pathways via glucagon
  • Comparisons with single- and triple-agonists
  • Incretin-axis metabolic research

Handling & documentation

In the laboratory this material is typically supplied as a lyophilized (freeze-dried) powder and reconstituted with bacteriostatic or sterile water for in-vitro work. As with any research compound, the quality signal that matters most is a lot-specific Certificate of Analysis (COA) from an independent lab, confirming identity by mass spectrometry and purity by HPLC. Store per the supplier’s guidance and verify the COA before use.

Browse the COA-verified research catalog →

For laboratory research use only. This content is educational and written for a research context. The compound is a research-use-only (RUO) material — not a drug, supplement, food, or cosmetic, not for human or veterinary use, and no claims are made to diagnose, treat, cure, or prevent any condition. No dosing or protocols are provided.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *